Medtronic reports 6% rise in quarterly revenue


David Maung | Bloomberg | Getty Images

An employee uses a microscope at the Medtronic assembly plant in Tijuana, Mexico.

Medical device maker Medtronic posted a better-than-expected quarterly profit on Tuesday, helped by strong performance across all segments.

The company’s top-selling cardiac and vascular unit that makes defibrillators, pace-makers, heart valves and stents raked in revenue of $2.86 billion, beating analysts’ estimate of $2.84 billion, according to IBES data from Refinitiv.

Medtronic’s minimally invasive therapies business, which makes surgical instruments and endoscopy products, brought in a revenue of $2.05 billion, ahead of analysts’ estimate of $2.01 billion.

The company also raised its full-year organic revenue forecast to a range of 5.0 percent to 5.5 percent from 4.5 percent to 5.0 percent.

Net income attributable to the company fell to $1.12 billion, or 82 cents per share, in the second quarter ended Oct. 26, from $2.02 billion, or $1.48 per share, a year earlier.

The company had a $235 million income tax provision in the reported quarter, compared with a $285 million tax benefit in the year-ago quarter.

Excluding items, Medtronic earned $1.22 per share, beating analysts’ expectations of $1.15 per share.

Net sales rose 6 percent to $7.48 billion, above estimates of $7.35 billion.

Source link

Products You May Like

Articles You May Like

FedEx just warned the whole globe is slowing
The Fed’s policy switch may be too late to save the economy
IRS giving millions a pass on penalties for 2018 underpayment
Tim Cook reportedly met with an vice premier in China
These people won’t have their taxes ready by April 15

Leave a Reply

Your email address will not be published. Required fields are marked *